Effects of Rivastigmine Transdermal Patch and Capsule on Aspects of Clinical Global Impression of Change in Alzheimer’s Disease: A Retrospective Analysis

Publisher： Karger

E-ISSN： 1421-9824|29|5|406-412

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.29, Iss.5, 2010-05, pp. : 406-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 150-162

Karger

Access to resources Recommend Favorite

Determinants of Global Clinical Change Assessment in Patients with Early Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-04 ,pp. : 157-163

Karger

Access to resources Recommend Favorite

Rivastigmine in the Treatment of Alzheimer’s Disease

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 110-110

Karger

Access to resources Recommend Favorite

Transdermal Is Better than Oral: Observational Research of the Satisfaction of Caregivers of Patients with Alzheimer’s Disease Treated with Rivastigmine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 35, Iss. 1-2, 2013-01 ,pp. : 23-33

Karger

Access to resources Recommend Favorite

Efficacy of Rivastigmine in Alzheimer’s Disease Patients with Rapid Disease Progression: Results of a Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 2-3, 2005-08 ,pp. : 192-197

Karger

Access to resources Recommend Favorite